Diabetic Retinopathy: A Position Statement by the American Diabetes Association
- PMID: 28223445
- PMCID: PMC5402875
- DOI: 10.2337/dc16-2641
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
Erratum in
-
Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.Diabetes Care. 2017 Jun;40(6):809. doi: 10.2337/dc17-er06e. Epub 2017 Apr 21. Diabetes Care. 2017. PMID: 28432087 Free PMC article. No abstract available.
-
Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.Diabetes Care. 2017 Sep;40(9):1285. doi: 10.2337/dc17-er09. Epub 2017 Jul 13. Diabetes Care. 2017. PMID: 28705833 Free PMC article. No abstract available.
Similar articles
-
Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.Diabetes Care. 2017 Jun;40(6):809. doi: 10.2337/dc17-er06e. Epub 2017 Apr 21. Diabetes Care. 2017. PMID: 28432087 Free PMC article. No abstract available.
-
Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.Diabetes Care. 2017 Sep;40(9):1285. doi: 10.2337/dc17-er09. Epub 2017 Jul 13. Diabetes Care. 2017. PMID: 28705833 Free PMC article. No abstract available.
-
Diabetic retinopathy.Med Clin North Am. 1978 Jul;62(4):767-85. Med Clin North Am. 1978. PMID: 355741 Review.
-
Proliferative retinopathy in patients with type 1 diabetes of less than 5 years' duration.Diabetes Metab. 2002 Apr;28(2):141-4. Diabetes Metab. 2002. PMID: 11976567
-
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008. J Am Coll Cardiol. 2009. PMID: 19147051 Review. No abstract available.
Cited by
-
Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy.Front Endocrinol (Lausanne). 2024 Oct 15;15:1462043. doi: 10.3389/fendo.2024.1462043. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39473506 Free PMC article.
-
Clinical Utility of Deep Learning Assistance for Detecting Various Abnormal Findings in Color Retinal Fundus Images: A Reader Study.Transl Vis Sci Technol. 2024 Oct 1;13(10):34. doi: 10.1167/tvst.13.10.34. Transl Vis Sci Technol. 2024. PMID: 39441571 Free PMC article.
-
Translational Research and Therapies for Neuroprotection and Regeneration of the Optic Nerve and Retina: A Narrative Review.Int J Mol Sci. 2024 Sep 29;25(19):10485. doi: 10.3390/ijms251910485. Int J Mol Sci. 2024. PMID: 39408817 Free PMC article. Review.
-
Bioinformatics analysis of immune infiltration in human diabetic retinopathy and identification of immune-related hub genes and their ceRNA networks.Sci Rep. 2024 Oct 14;14(1):24003. doi: 10.1038/s41598-024-75055-3. Sci Rep. 2024. PMID: 39402134 Free PMC article.
-
Prevalence and Progression of Diabetic Retinopathy in a Tertiary Care Setting: An Initial Review With Recommended Screening Protocols.Cureus. 2024 Sep 12;16(9):e69296. doi: 10.7759/cureus.69296. eCollection 2024 Sep. Cureus. 2024. PMID: 39398801 Free PMC article.
References
-
- American Diabetes Association Diabetic retinopathy. Diabetes Care 2002;25(Suppl. 1):S90–S93
-
- Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis 1998;31:947–953 - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
